317120 — Ranix Balance Sheet
0.000.00%
- KR₩24bn
- KR₩39bn
- KR₩8bn
Annual balance sheet for Ranix, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,584 | 8,463 | 12,987 | 8,339 | 2,322 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,273 | 2,088 | 2,435 | 1,514 | 2,569 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,045 | 14,743 | 17,406 | 11,784 | 6,154 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 17,575 | 17,548 | 17,268 | 17,041 | 36,385 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 32,348 | 45,115 | 41,975 | 29,229 | 43,085 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,509 | 1,344 | 27,535 | 6,203 | 14,247 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 15,176 | 25,782 | 27,653 | 18,597 | 23,530 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 17,171 | 19,333 | 14,322 | 10,632 | 19,555 |
Total Liabilities & Shareholders' Equity | 32,348 | 45,115 | 41,975 | 29,229 | 43,085 |
Total Common Shares Outstanding |